Items where authors include "Bissell, L.A."

Article

Zahed Mohajerani, S., Altaie, A., Minerba, M. et al. (6 more authors) (2025) OP0377 Acid Reflux Triggers Type I Interferon and epithelial-mesenchymal transition in Esophageal Epithelial Cells, in vitro. A new potential microenvironment contribution to the pathogenesis of Systemic Sclerosis. Annals of the Rheumatic Diseases, 84 (Supplement 1). ISSN 0003-4967

Conference or Workshop Item

Colak, S.Y., Di Donato, S., Bixio, R. et al. (6 more authors) (2025) POS0497 12 months sensitivity to change and clinical important differences of EULAR ScleroID: a comprehensive pro measuring impact of systemic sclerosis on how patients feel and function. In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Proceedings Paper

Colak, S.Y., Di Donato, S., Bixio, R. et al. (6 more authors) (2025) POS0497 12 MONTHS SENSITIVITY TO CHANGE AND CLINICAL IMPORTANT DIFFERENCES OF EULAR ScleroID: A COMPREHENSIVE PRO MEASURING IMPACT OF SYSTEMIC SCLEROSIS ON HOW PATIENTS FEEL AND FUNCTION. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier .

Kaye, E., Osborne, T., Thornton, L. et al. (4 more authors) (2025) POS0516 Applicability of the phase 3 Trial DAISY (Detecting effectiveness of Anifrolumab In SYstemic Sclerosis) inclusion criteria to the general SSc population – a study from the EUSTAR cohort. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. .

Thornton, L., De Lorenzis, E., Di Donato, S. et al. (4 more authors) (2025) ABS0950 ARTIFICIAL INTELLIGENCE ANALYSIS OF HRCT IMAGES REFLECTS PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , p. 2317.

Mohajerani, S.Z., Altaie, A., Minerba, M. et al. (6 more authors) (2025) OP0377 Acid Reflux Triggers Type I Interferon and epithelial-mesenchymal transition in Esophageal Epithelial Cells, in vitro. A new potential microenvironment contribution to the pathogenesis of Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , p. 304.

Minerba, M., Çolak, S., Di Donato, S. et al. (5 more authors) (2025) POS0485 SEVERE GASTROINTESTINAL INVOLVEMENT IN SYSTEMIC SCLEROSIS: A NEW “TRANSVERSAL” SUBSET OF DISEASE TO BE PRIORITISED FOR INTERVENTION TRIALS. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 705-706.

Minerba, M., Colak, S., Di Donato, S. et al. (5 more authors) (2025) POS0485 SEVERE GASTROINTESTINAL INVOLVEMENT IN SYSTEMIC SCLEROSIS: A NEW “TRANSVERSAL” SUBSET OF DISEASE TO BE PRIORITISED FOR INTERVENTION TRIALS. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jul 2025, Barcelona, Spain. Elsevier , pp. 705-706.

Kaye, E., Osborne, T., Thornton, L. et al. (4 more authors) (2025) POS0516 Applicability of the phase 3 Trial DAISY (Detecting effectiveness of Anifrolumab In SYstemic Sclerosis) inclusion criteria to the general SSc population – a study from the EUSTAR cohort. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , p. 730.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Bissell, L.A., Huang, S. et al. (4 more authors) (2023) POS0338 Development And Validation Of Ranked Composite Important Difference (RCID) Score In Diffuse Cutaneous Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 416.